更新于 1月9日

体内肿瘤高级研究员

2.2-3万
  • 上海浦东新区
  • 经验不限
  • 博士
  • 全职
  • 招1人

雇员点评标签

  • 工作环境好
  • 同事很nice
  • 团队执行强
  • 氛围活跃
  • 人际关系好
  • 免费班车
  • 交通便利
  • 非常锻炼人

职位描述

体内肿瘤
Responsibilities:
1.Comply with company rules and regulations, follow the supervisor
s work arrangements, and be able to complete the experimental progress with quality and quantity on time;
2.Independently perform in vivo pharmacology experiments according to the protocol, including tumor inoculation (subcutaneous and orthotopic), compound preparations, administration (IV, PO, IP, SC, etc.), tumor volume measurement, animal dissection, and tissue sampling;
3.Compliantly maintain experimental records, analyze experimental data, write experimental reports in both Chinese and English, and complete data archiving. Regularly report project progress as required;
4.Communicate pharmacology and efficacy research projects with domestic and international clients based on project needs, complete project signing, assist clients in resolving issues that arise during the project, undertake troubleshooting tasks, and deliver high-quality project data;
5.Participate in the daily operation and maintenance of the laboratory and instrument management, excel at identifying and solving problems encountered in projects or the laboratory, and complete other tasks assigned by the supervisor.
Requirements:
1.PhD degree in oncology, immunology, pharmacology, or related biology fields. Candidates with in vivo tumor pharmacology and efficacy experiment experience are preferred;
2.Preference will be given to candidates with excellent spoken English skills and experience studying abroad;
3.Adept at learning and communication, with strong self-learning, data analysis, and interpretation skills. Prioritizes efficiency in work and avoids procrastination;
4.Proficient in using data analysis software such as Office, GraphPad, and SPSS;
5.Possesses strong teamwork and communication skills.

工作地点

浦东新区中国上海外高桥自贸区富特中路288号

职位发布者

刘先生/资深人力资源

当前在线
立即沟通
公司Logo药明康德新药开发有限公司公司标签
药明康德(股票代码:603259.SH/2359.HK)为全球医药及生命科学行业提供一体化、端到端的新药研发和生产服务,在亚洲、欧洲、北美等地均设有运营基地。药明康德通过独特的“CRDMO”业务模式,不断降低研发门槛,助力客户提升研发效率,为患者带来更多突破性的治疗方案,服务范围涵盖化学药研发和生产、生物学研究、临床前测试和临床试验研究等领域。2024年,药明康德连续第四年被MSCI评为ESG(环境、社会及管治)AA级。目前,公司的赋能平台正承载着来自全球30多个国家约6,000家合作伙伴的研发创新项目,致力于将更多新药、好药带给全球病患,早日实现“让天下没有难做的药,难治的病”的愿景。
公司主页